Poultry Vaccines Market By Type (Live Vaccines and Killed Vaccines), By Application (Chicken and Duck & Goose), and By Region - Trends, Analysis and Forecast till 2030

Poultry Vaccines Market accounted for USD 1.98 Billion in 2020 and is estimated to be USD 3.47 Billion by 2030 and is anticipated to register a CAGR of 5.8%.

Poultry Vaccines plays an important role in preventing the health of poultry flock. There are many diseases that are reduced by vaccinating the poultry flock. Vaccine produce antibodies that helps birds body to fight again invading causal organisms. Poultry vaccinations are an important part of disease prevention and control in poultry. A vaccine aids in the prevention of a disease by stimulating the immune system of the bird to make antibodies that fight the invading pathogens. Many vaccine are efficacy and, as a result, the level of immunity developed by the bird are affected by how they are handled and administered. The majority of vaccines used to kill chickens are designed to protect against viral infections. A poultry vaccination programme is determined by various elements, including the kind of production, level of biosecurity, local disease patterns, maternal immunity status, vaccine availability, and costs and possible losses. Vaccines are given in a variety of ways, including in vivo, intramuscular, subcutaneous, ocular, oral, and nasal. Vaccines can be used on the air cell, allantoic sac, amniotic fluid, embryo body, and yolk sac, among other parts of the egg. In vivo vaccination requires hygiene management, which includes reduced air movement, well-maintained air filters, weather adjustments, and well-maintained hatchery insulation.

Increasing vaccine innovation, cost-effective animal health expenditure, rising demand for poultry vaccination, poultry-derived food products, technological advancement, rising prevalence of zoonotic disease, rising poultry population, rising government initiative in poultry treatment, and increasing vaccination programme by leading industries are the driving factors. The increasing cost of vaccination, increasing adoption of vegetarian food, decreasing manufacturing of advanced vaccine, and increasing investment in animal health are all factors that are limiting the market growth of poultry vaccine. A significant market leader has announced the debut of a new product with enhanced capabilities. They've made the required steps to improve device accuracy and overall operation. MSD Animal Health has developed the world's first dual construct Herpes Virus of Turkeys (HVT) vaccine, which protects birds against infectious Bursal, Newcastle, and Mareck's disease. The AvinewTM Neo Effervescent tablet vaccine, developed by Merial, Sanofi's animal health subsidiary, aids in the treatment of Newcastle Disease Virus (NDV). The "Merial Avinew Vaccine" is the most widely used vaccine in the world.

The Global Poultry Vaccine Market is segmented based on the type, application and region.

By Type, the market is segmented into Live Vaccines and Killed Vaccines. By Application, the market is segmented into Chicken and Duck & Goose.

Regional Insights:

On region the global poultry vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Due to technical advancements, rising chicken inventories, rising demand for poultry-derived goods, and increased investment in animal health, North America dominates the worldwide poultry vaccines market. The National Chicken Council estimates that per capita poultry consumption was 107.6 pounds in 2016 and will rise to 109.5 pounds in 2018. Europe is the world's second-largest poultry vaccination market. Due to expanding chicken output, government immunisation programmes, and veterinary health care expenditure, Asia Pacific is predicted to rise at a rapid pace. In the near future, these factors are expected to boost the Asia Pacific market.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global poultry vaccine market report based on Type, Application and Region.

Global Poultry Vaccine Market, By Region:

• North America
  • • • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Key players in the global poultry vaccines market includes Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Merck and Co., Inc., Zoetis, Inc., Ceva Animal Health, Inc., Phibro Animal Health Corporation, Venkys Ltd., Intervac Pvt Ltd, Anicon GmbH and ASP, Inc.

• Boehringer Ingelheim GmbH
• Elanco Animal Health Incorporated
• Merck and Co., Inc.
• Zoetis, Inc.
• Ceva Animal Health, Inc.
• Phibro Animal Health Corporation
• Venkys Ltd.
• Intervac Pvt Ltd
• Anicon GmbH
• ASP, Inc.